Be The Match BioTherapies

Be The Match BioTherapies was founded as an extension of the National Marrow Donor Program (NMDP) to leverage its extensive experience in cell and gene therapy. The organization’s core mission is to advance the development and delivery of life-saving therapies by providing comprehensive solutions for cell and gene therapy developers. Their services include allogeneic cell sourcing, cord blood unit sourcing, and GMP-compliant leukopak collections, catering to both autologous and allogeneic therapy needs. Be The Match BioTherapies focuses on reducing risks and streamlining processes for therapy developers, ultimately aiming to improve patient outcomes.

Notable affiliated individuals include leaders from the NMDP, who bring decades of expertise in donor matching and cellular therapy. The organization has garnered support from key investors and stakeholders within the healthcare and biotech sectors. Among its significant achievements is the successful facilitation of numerous cell and gene therapy clinical trials, contributing to advancements in treatment options for various diseases. Be The Match BioTherapies has made a substantial impact by enhancing the efficiency and reliability of cell and gene therapy development, thereby accelerating the availability of innovative treatments to patients in need.